Effects Of Antibacterial Agents On Dental Pulps Of Monkeys Mechanically Exposed And Contaminated

Objective: The purpose of this study was to compare the effectiveness of antibacterial agents and mineral trioxide aggregate in the healing of bacterial contaminated primate pulps. Study Design: The experiment required four adult male primates (Cebus opella) with 48 teeth prepared with buccal penetrations into the pulpal tissues. The preparations were performed under general anesthesia and the exposed pulps were exposed to cotton pellets soaked in a bacterial mixture consisting of microorganisms normally found in human pulpal abscesses obtained from the Endodontic Clinic of UNESP. Following bacterial inoculation (30 minute exposure), the pulpal tissue was immediately treated with either sterile saline, Cipro HC Otic solution(12), diluted Buckley' formecresol solution (12) or Otosporin otic solution (12) for 5 minutes. After removal of the pellet, hemostasis was obtained and a ZOE base applied to the DFC treated pulps and the non-treated controls (12). After hemostasis, the other exposed pulps were covered with mineral trioxide aggregate (ProRoot). The pulpal bases were all covered with a RMGI (Fuji II LC). The tissue samples were collected at one day, two days, one week and over four weeks (34 days). Results: Following perfusion fixation,the samples were demineralized, sectioned, stained and histologically graded. After histologic analysis,presence of neutrophilic infiltrate and areas of hemorrhage with hyperemia were observed. The depth of the neutrophilic infiltrate depended on the agent or material used. The pulpal tissue treated with Otic suspensions demonstrated significantly less inflammation (Kruskal Wallis non parametric analysis, H=9.595 with 1 degree of freedom; P=0.0223) than the formocresol and control groups. The hard tissue bridges formed over the exposure sites were more organized in the MTA treatment groups than in the control and ZOE groups (Kruskal Wallis non parametric analysis, H=18.291 with 1 degree of freedom; P=0.0004).Conclusions: Otic suspensions and MTA are effective in treating bacterial infected pulps and stimulate the production of a hard tissue bridge over the site of the exposure.

pulp exposures, pulp response, bacteria, primates

1. Kanca J, Replacement of a fractured incisor fragment over pulpal expo-sure: a case report. Quintessence Int, 24(2): 81–4, 1993.

2. Kanca J, Replacement of a fractured incisor fragment over pulpal expo-sure: a long term case report. Quintessence Int, 27(12): 829–32, 1996.

3. Trope M et al, Capping the inflamed pulp under different clinical con-ditions. J Esthet Restor Dent, 14(6): 349–57, 2002.

4. Percinoto C et al, Clinical and radiographic evaluation of pulpotomies employing calcium hydroxide and trioxide mineral aggregate. Gen Dent, 54(4): 258–61, 2006.

5. Russo MC, Holland R, Okamoto T, de Mell W. In vivo fixative effect of formocresol on pulpotomized deciduous teeth of dogs. Oral Surg, 58: 706–14, 1984.

6. Pashley EL, Myers DR, Pashley DH, Whitford GM, Systemic distribu-tion of 14C-formaldehyde from formocresol-treated pulpotomy sites. J Dent Res, 59(3): 602–8, 1980.

7. Waterhouse, P.J. Formocresol and alternative primary molar pulpotomy medicaments: a review. Endod. Dent. Traumatol, 11: 157–62, 1995.

8. Fuks, A. Pulp therapy for the primary and young permanent dentitions. Dent Clin North Am, 44(5), 2000.

9. Ranly, DM. Pulpotomy therapy in primary teeth: new modalities for old relationales. Pediatr. Dent,16: 403–9, 1994.

10. Waterhouse, P.J. Nunn JH, Whitworth JM, Soames JV. Primary molar pulp therapy-histological evaluation of failure. Int J Paediatr Dent, 10: 313–321, 2000.

11. Blanco L, Cohen S, Treatment of crown fractures with exposed pulps. J Calif Dent Assoc, 30(6): 419–25, 2002.

12. Kupietzky A, Holan G, Treatment of crown fractures with pulp expo-sures in primary incisors. Pediatr Dent, 25(3): 241–7, 2003.

13. Mejare I, Cvek M, Partial pulpotomy in young permanent teeth with deep carious lesions. Endod Dent Traumatol, 9(6): 238–42, 1993.

14. Syizero Nda R, et al, Partial pulpotomy and tooth reconstruction of a crown-fractured permanent incisor: a case report. Quintessence Int, 34(10): 740–7, 2003.

15. deBlanco LP, Treatment of crown fracture with pulp exposure. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 82(5): 564–8, 1996.

16. Pitt Ford TR, Roberts GJ. Immediate and delayed direct pulp capping with the use of a new visible light-cured calcium hydroxide prepara-tion. Oral Surg Oral Med Oral Pathol, 71(3): 338–42, 1991.

17. Torabinejad M, Watson TF, Pitt Ford TR. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J. Endod, 12: 591–95, 1993.

18. Torabinejad, M. et al. Physical and chemical properties of a new root-end filling material. J. Endod, 21: 349–353, 1995.

19. Lee S, Monsef M., Torabinejad M. Sealing ability of a mineral trioxide aggregate for repair of lateral root perforations. J. Endod. 19. nov. 1993.

20. Aqrabawi J. Sealing ability of amalgam, Super EBA cement, and MTA when used as retrograde filling materials. Br. Dent. J, 188: 266–268, 2000.

21. Torabinejad M, Ford TR, Abedi HR, Kariyawasam SP, Tang HM.. Tis-sue reaction to implanted Super EBA and mineral trioxide aggregate in the mandible of guinea pigs: a preliminary report. J. Endod, 21: 569–71, 1995.

22. Koh ET, Torabinejad M, Pitt Ford TR, Brady K, McDonald F. Mineral trioxide aggregate stimulates a biological response in human osteoblasts. J. Biomed. Mat Res, 37: 432–9, 1997.

23. Moretton TR, Brown CE JR, Legan JJ, Kafrawy AH. Tissue reactions after subcutaneous and intraosseous implantation of mineral trioxide aggregate and ethoxybenzoic acid cement. J. Biomed. Mater. Res, 52: 528–533, 2000.

24. Kettering JD, Torabinejad M. Investigation of mutagenicity of mineral trioxide aggregate and other commonly used root-end filling materials. J. Endod, 21, 1995.

25. Keiser K, Johnson C, Tipton DA. Citotoxicity of mineral trioxide aggregate using human periodontal ligament fibroblasts. J. Endod, 26: 288–291, 2000.

26. Koh ET, McDonald F, Pitt Ford TR, Torabinejad M. Cellular response to mineral trioxide aggregate. J. Endod, 24: 543–7, 1998.

27. Abedi HR et al. The use of mineral trioxide aggregate cement as a direct pulp capping agent. J. Endod, 22: 199, 1996.

28. Schwartz RS, Mauger M, Clement DJ, Walker WA 3rd.. Mineral triox-ide aggregate: anew material for endodontics. J. Am. Dent. Assoc, 30: 969–75, 1999.

29. Holland R, Souza V, Nery MJ, Faraco Junior IM, Bernabe PF, Otoboni Filho JA, Dezan Junior E. Reaction of rat connective tissue to implanted dentin tube filled with mineral trioxide aggregate, portland cement or calcium hydroxide. Braz. Dent. J, 112: 3–8, 2001.

30. Holland R, Souza V, Nery MJ, Faraco Junior IM, Bernabe PF, Otoboni Filho JA, Dezan Junior E.. Reaction of rat connective tissue to implanted dentin tubes filled with mineral trioxide aggregate or cal-cium hydroxide. J. Endod, 25,(3): 161–6, 1999.

31. Ford TR, Torabinjad M, Abedi HR, Bakland LK, Kaylyawawam SP. Using mineral trioxide aggregate as a pulp capping material. J. Am. Dent. Assoc, 127(10): 1491–4, 1996.

32. Eidelman E, Holan G, Fuks AB. Mineral trioxide aggregate versus formocresol in pulpotomized primary molars: a preliminary report. Pediatr. Dent, 23: 5–8, 2001.

33. Sato I, Ando-Kunhara N, Kota K, Iwaku M, Hoshino E. Sterilization of infected root-canal dentine by topical application of a mixture of ciproflxacin, metronidazole and minocycline in situ. Int Endod J, 29(2): 118–24, 1996.

34. Yoshiba K, Yoshiba N, Iwaku M, Effects of anti-bacterial capping agents on dental pulps of monkeys mechanicaly exposed to oral microflora. J Endod, 21(1): 16–20, 1995.

35. Zarzar PA et al, Formocresol mutagenicity following primary tooth pulp therapy: an in vivo study. J Dent, 31(7): 479–85, 2003.

36. Holan G, Eidelman E, Fuks AB. Long-term evaluation of pulpotomy in primary molars using mineral trioxide aggregate or formocresol. Pedi-atr. Dent, 27(2): 129–36, 2005.

37. Maroto M, Barberia E, Planells R, Garcia Godoy F. Dentin bridge for-mation after mineral trioxide aggregate (MTA) pulpotomies in primary teeth. Am J Dent, 18(3): 151–4, 2005.

38. Torabinejad, M., Chivian, N. Clinical applications of mineral trioxide aggregate. J. Endod, 25: 97–205, 1999.

39. Love RM, Bacterial adhesins- their role in tubule invasion and endodontic disease. Aust Endod J, 28: 25–8, 2002.

40. Ando N., Hoshino E. Predominant obigate anaerobes invading the deep layers of root canal dentin. Int Endod J, 23(1): 20–7, 1990.

41. Srinivasan V, Patchett CL, Waterhouse PJ. Is there life after Buckley’s Formocresol? Part I- a narrative review of alternative interventions and materials. Int J Paediatr Dent, 16(2): 117–27, 2006.

42. Alliot-Licht B, Bluteau G, Magne D, Lopez-Cazaux S, Lieubeau B, Dalculsi G, Guicheux J. Dexamethasone stimulates differentiation of odontoblast-like cells in human dental pulp cultures. Cell Tissue Res, 321(3): 391–400, 2005.

43. Sato T, Hoshino E, Usematsu H, Noda T. In vitro antimicrobial suscep-tibility to combinations of drugs on bacteria from carious and endodon-tic lesions of human deciduous teeth. Oral Microbiol. Immunol, 8(3): 172–6, 1993.

44. Oliveria LD, Leao MV, Carvalho CA, Camargo CH, Valera MC, Jorge AO, Unterkircher CS. In vitro effects of calcium hydroxide and polymyxin B on endotoxins in root canals. J. Dent, 33(2): 107–14, 2005.

45. Faraco junior IM, Holland R. Histomorphological response of dog’s dental pulp capped with white mineral trioxide aggregate. Braz Dent J, 15: 104–8, 2004.

46. Percinoto C, Russo MC. O hidróxido de cálcio e o processo de reparo em dentes pulpotomizados. In: Atualização na clínica odontológica. São Paulo: Artes Médicas. 98–310, 2000.